Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+१.८४%
१,११४.९९
+२०.१५
+१.८४%
१,०९४.८४१,१०७.९११,११९.१११,१०७.९१
SIXC
Communications
SIXC
Communications
SIXC
+१.५८%
६१३.७७
+९.५६
+१.५८%
६०४.२१६०४.२१६१४.७३६०४.२१
SIXE
Energy
SIXE
Energy
SIXE
-३.८६%
१,२०१.४६
-४८.२५
-३.८६%
१,२४९.७११,२१९.४६१,२१९.४६१,१९१.६६
SIXI
Industrials
SIXI
Industrials
SIXI
+२.०९%
१,७७५.५५
+३६.२९
+२.०९%
१,७३९.२६१,७५४.१११,७८३.९६१,७५४.११
SIXM
Financials
SIXM
Financials
SIXM
+०.५९%
६३९.४०
+३.७७
+०.५९%
६३५.६३६३७.४६६४३.४२६३७.४६
SIXR
Staples
SIXR
Staples
SIXR
-०.०४%
८४७.८९
-०.३६
-०.०४%
८४८.३२८५०.९०८५३.०५८४६.६८
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+१.५५%
२२०.१२
+३.३६
+१.५५%
२१६.७६२१६.७६२२०.४०२१६.७६
SIXT
Technology
SIXT
Technology
SIXT
+१.६२%
३,३८९.१२
+५३.९८
+१.६२%
३,३३५.१४३,३७६.१३३,४०६.१२३,३६०.२९
SIXU
Utilities
SIXU
Utilities
SIXU
-१.१६%
९२८.४१
-१०.९३
-१.१६%
९३९.३४९३७.३२९३७.५९९२४.४८
SIXV
Health care
SIXV
Health care
SIXV
-०.१४%
१,४६६.०८
-२.०९
-०.१४%
१,४६८.१७१,४६८.९८१,४७६.५०१,४६५.३६
SIXY
Discretionary
SIXY
Discretionary
SIXY
+१.३३%
२,४१८.८७
+३१.७८
+१.३३%
२,३८७.०९२,३९४.१८२,४२१.७४२,३९४.१८
BCTX:NASDAQ
Briacell Therapeutics Corp
US$ ४.०९
+०.४९%
(+०.०२०) 1D
मे ६, १३:०२:०९ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BCTX...
Open
US$ ४.१५
High
US$ ४.२१
Low
US$ ४.०१
Mkt. cap
४.०३ करोड
Avg. vol.
१.५१ लाख
Volume
१.६१ लाख
52-wk high
US$ ३८.३०
52-wk low
US$ ३.६०
Beta
१.२६
Shares outstanding
७२.५० लाख
No. of employees
२२
News stories
From sources across the web
Investing.com
Investing.com
·
५ घण्टा पहिले
BriaCell receives FDA clearance for breast cancer therapy trial
Stock Titan
Stock Titan
·
५ घण्टा पहिले
FDA clears BriaCell's personalized breast cancer study to start
Newser
Newser
·
१ महिना पहिले
BCTX Pulls Back: Market Rotation Hits Healthcare
About Briacell Therapeutics Corp
CEO-
Employees२२
Founded२००६
HeadquartersWest Vancouver, ब्रिटिश कोलम्बिया, क्यानाडा
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ अप्रिल
२०२५ जुलाई
२०२५ अक्टोबर
२०२६ जनवरी
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
४६.९६ लाख
६९.९६ लाख
६५.५९ लाख
५९.२३ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१६.३२ लाख
१५.५८ लाख
१७.६४ लाख
१६.०८ लाख
Operating expense
६३.२८ लाख
८५.५४ लाख
८३.२३ लाख
७५.३१ लाख
Total operating expenses
६३.२८ लाख
८५.५४ लाख
८३.२३ लाख
७५.३१ लाख
Operating income
-६३.२८ लाख
-८५.५४ लाख
-८३.२३ लाख
-७५.३१ लाख
Other non operating income
१.७६ लाख
३.९२ लाख
-६९.२० हजार
२.१२ लाख
EBT including unusual items
-६२.२५ लाख
-८१.६४ लाख
-८२.७८ लाख
-७२.९७ लाख
EBT excluding unusual items
-६२.२५ लाख
-८२.२१ लाख
-८३.६८ लाख
-७२.९७ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-६१.२७ लाख
-८०.९१ लाख
-८१.९८ लाख
-७२.२२ लाख
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
२६.६३ हजार
३३.४४ हजार
४८.४८ हजार
१.०६ लाख
Interest expense
-३६.९८ हजार
-
-
-
Net interest expenses
-१०.३५ हजार
३३.४४ हजार
४८.४८ हजार
१.०६ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-६३.०२ लाख
-८५.२८ लाख
-८२.९६ लाख
-७५.०५ लाख
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more